BSX vs FDSB · P/E 20, rev $20.07B vs P/E 18, rev $605.0K
Boston Scientific Corp (BSX) versus Fifth District Bancorp, Inc. Common Stock (FDSB) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Fifth District Bancorp, Inc. Common Stock (FDSB) is a banks - regional company listed on US.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported FDSB revenue for 2025-12-31 was $605.0K. Net income was $4.1M. Revenue was down 2.3% from 2024-12-31 to 2025-12-31. FDSB currently screens at market cap $79.3M and trailing P/E 17.5.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. FDSB currently screens at market cap $79.3M and trailing P/E 17.5.
Not investment advice. Open the BSX and FDSB stock pages for the full models.
Not investment advice.